| Secondary |
| Bipolar I Disorder |
17.4% |
| Schizophrenia, Paranoid Type |
16.7% |
| Bipolar Disorder |
10.1% |
| Drug Use For Unknown Indication |
6.6% |
| Product Used For Unknown Indication |
6.6% |
| Constipation |
5.9% |
| Depression |
5.9% |
| Mania |
5.6% |
| Schizophrenia |
5.6% |
| Parkinson's Disease |
4.2% |
| Interstitial Lung Disease |
3.5% |
| Insomnia |
2.4% |
| Affective Disorder |
2.1% |
| Major Depression |
2.1% |
| Hypertension |
1.7% |
| Partial Seizures |
1.0% |
| Anxiety |
0.7% |
| Benign Prostatic Hyperplasia |
0.7% |
| Delusional Disorder, Unspecified Type |
0.7% |
| Depressive Symptom |
0.7% |
|
| Therapeutic Agent Toxicity |
12.7% |
| Somnolence |
10.9% |
| Liver Disorder |
7.3% |
| Stevens-johnson Syndrome |
7.3% |
| Tremor |
7.3% |
| White Blood Cell Count Increased |
7.3% |
| Renal Impairment |
5.5% |
| Somnolence Neonatal |
5.5% |
| Vomiting |
5.5% |
| Delirium |
3.6% |
| Malaise |
3.6% |
| Neuroleptic Malignant Syndrome |
3.6% |
| Rash |
3.6% |
| Sick Sinus Syndrome |
3.6% |
| Water Intoxication |
3.6% |
| Anaphylactic Reaction |
1.8% |
| Aspartate Aminotransferase Increased |
1.8% |
| Autoimmune Thyroiditis |
1.8% |
| Blood Creatine Phosphokinase Increased |
1.8% |
| Decreased Appetite |
1.8% |
|
| Concomitant |
| Bipolar Disorder |
16.2% |
| Bipolar I Disorder |
15.2% |
| Depression |
12.5% |
| Insomnia |
8.1% |
| Schizophrenia |
6.7% |
| Schizophrenia, Paranoid Type |
5.1% |
| Product Used For Unknown Indication |
4.6% |
| Sleep Disorder |
4.0% |
| Schizophrenia, Disorganised Type |
3.9% |
| Constipation |
3.6% |
| Substance-induced Psychotic Disorder |
3.5% |
| Asthma |
2.7% |
| Prophylaxis |
2.6% |
| Schizophrenia, Undifferentiated Type |
2.2% |
| Hypertension |
1.7% |
| Anxiety |
1.6% |
| Bipolar Ii Disorder |
1.6% |
| Drug Use For Unknown Indication |
1.5% |
| Schizoaffective Disorder |
1.3% |
| Hyperlipidaemia |
1.3% |
|
| White Blood Cell Count Increased |
13.5% |
| Vomiting |
10.7% |
| Rhabdomyolysis |
9.6% |
| Rash |
8.4% |
| White Blood Cell Count Decreased |
6.7% |
| Tremor |
5.6% |
| Stevens-johnson Syndrome |
4.5% |
| Mania |
3.9% |
| Pyrexia |
3.9% |
| Sudden Death |
3.9% |
| Completed Suicide |
3.4% |
| Salivary Hypersecretion |
3.4% |
| Serotonin Syndrome |
3.4% |
| Hepatic Function Abnormal |
2.8% |
| Interstitial Lung Disease |
2.8% |
| Neuroleptic Malignant Syndrome |
2.8% |
| Rash Generalised |
2.8% |
| Skin Disorder |
2.8% |
| Suicidal Ideation |
2.8% |
| Granulocyte Count Decreased |
2.2% |
|
| Interacting |
| Depressed Mood |
33.3% |
| Depressive Symptom |
33.3% |
| Gonarthrosis |
33.3% |
|
| Somatoform Disorder Neurologic |
50.0% |
| Somnolence |
50.0% |
|
